Evidence map›Paper›PMID 33103069›Full record

ArticleiScience2020

Diminished Sphingolipid Metabolism, a Hallmark of Future Type 2 Diabetes Pathogenesis, Is Linked to Pancreatic β Cell Dysfunction.

Saifur R Khan, Yousef Manialawy, Andreea Obersterescu, Brian J Cox, Erica P Gunderson, Michael B Wheeler

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in iScience, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01967030 (SWIFT), which is not on this map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01967030 active not recruitingnot on this map

SWIFT: Study of Women, Infant Feeding and Type 2 Diabetes After GDM Pregnancy

TypeobservationalSponsorKaiser PermanenteRan2008 to 2030Enrolled1,035ConditionsType 2 Diabetes
3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 32 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Stool and blood metabolomics in the metabolic syndrome: a cross-sectional study.Metabolomics : Official journal of the Metabolomic Society · 2024
    Article
  9. Review
  10. Pharmacometabolomics of sulfonylureas in patients with type 2 diabetes: a cross-sectional study.Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques · 2024
    Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Saifur R KhanDepartment of Physiology, University of Toronto, ON, Canada.
Yousef ManialawyDepartment of Physiology, University of Toronto, ON, Canada.
Andreea ObersterescuDepartment of Physiology, University of Toronto, ON, Canada.
Brian J CoxDepartment of Physiology, University of Toronto, ON, Canada.
Erica P GundersonKaiser Permanente Northern California, Division of Research, Oakland, CA, USA.
Michael B WheelerDepartment of Physiology, University of Toronto, ON, Canada.
Toronto General Hospital · CAUniversity of Toronto · CAKaiser Permanente · US

Funding

Metabolite Profiles Preceding Progression to Diabetes Mellitus after Gestational DiabetesR01DK118409 · NIDDK · KAISER FOUNDATION RESEARCH INSTITUTE · PI GUNDERSON, ERICA PAULINE · 2018 to 2023
$3.1M
Lactation and Glucose Tolerance After GDM PregnancyR01HD050625 · NICHD · KAISER FOUNDATION RESEARCH INSTITUTE · PI GUNDERSON, ERICA PAULINE · 2007 to 2011
$3.1M
NICHD NIH HHS R01 HD050625NIDDK NIH HHS R01 DK118409
6 · The paper itself

Abstract

Gestational diabetes mellitus (GDM) is the top risk factor for future type 2 diabetes (T2D) development. Ethnicity profoundly influences who will transition from GDM to T2D, with high risk observed in Hispanic women. To better understand this risk, a nested 1:1 pair-matched, Hispanic-specific, case-control design was applied to a prospective cohort with GDM history. Women who were non-diabetic 6-9 weeks postpartum (baseline) were monitored for the development of T2D. Metabolomics were performed on baseline plasma to identify metabolic pathways associated with T2D risk. Notably, diminished sphingolipid metabolism was highly associated with future T2D. Defects in sphingolipid metabolism were further implicated by integrating metabolomics and genome-wide association data, which identified two significantly enriched T2D-linked genes,

Indexed as

BioinformaticsGenomicsHuman PhysiologyPathophysiologySystems Biology

Identifiers

PMID33103069
PMCPMC7578680
OpenAlexW3085433892

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.